Cell And Gene Therapy CDMO Market By Service Type (Process Development, Manufacturing Services, Analytical & Quality Services, Fill-Finish & Packaging Services, Regulatory & Consulting Services), By Application (Oncology, Rare Genetic Disorders, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Ophthalmology, Others), By Therapy Type (Cell Therapy CDMO, Gene Therapy CDMO), By Stages (Preclinical Development, Clinical Trials Manufacturing, Commercial Manufacturing, Lifecycle Management), and By End User (Biotechnology Companies, Pharmaceutical Companies, Academic & Research Institutes, Hospitals & Clinical Centers), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & Forecast Parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Cell And Gene Therapy CDMO Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. How does increasing demand for personalized medicine accelerate market growth?

3.2.2. Can technological advancements in bioprocessing enhance production efficiency?

3.2.3. Will rising investments in biotech startups drive contract manufacturing expansion?

3.3. Key industry pitfalls & challenges

3.3.1. What impact do stringent regulations have on therapy development timelines?

3.3.2. Could high production costs limit accessibility and widespread adoption?

3.3.3. Are limited skilled workforce challenges slowing manufacturing scale-up?

3.4. Market Opportunities

3.4.1. How can emerging markets expand customer base for CDMO services?

3.4.2. Will collaborations with pharma giants create new innovation avenues?

3.4.3. Can automation integration reduce errors and boost process reproducibility?

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Cell And Gene Therapy CDMO Market, Service Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Service Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Process Development

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Manufacturing Services

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Analytical & Quality Services

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.5. Fill-Finish & Packaging Services

4.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.6. Regulatory & Consulting Services

4.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Cell And Gene Therapy CDMO Market, Application Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Application, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Oncology

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Rare Genetic Disorders

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Cardiovascular Diseases

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Neurological Disorders

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.6. Infectious Diseases

5.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.7. Ophthalmology

5.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.8. Others

5.8.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Cell And Gene Therapy CDMO Market, Therapy Type Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Therapy Type, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Cell Therapy CDMO

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Gene Therapy CDMO

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Cell And Gene Therapy CDMO Market, Stages Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Stages, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Preclinical Development

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Clinical Trials Manufacturing

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Commercial Manufacturing

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.5. Lifecycle Management

7.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Cell And Gene Therapy CDMO Market, End-user Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By End-user, 2025 & 2035

8.1.2. Key Market Trends, Growth Factors, & Opportunities

8.2. Biotechnology Companies

8.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.3. Pharmaceutical Companies

8.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.4. Academic & Research Institutes

8.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.5. Hospitals & Clinical Centers

8.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

9. Cell And Gene Therapy CDMO Market, Region Segment Analysis

9.1. Overview

9.1.1. Global Market Revenue Share, By Region, 2025 & 2035

9.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

9.2. North America

9.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

9.2.2. North America Market Revenue, By Service Type, 2025-2035

9.2.3. North America Market Revenue, By Application, 2025-2035

9.2.4. North America Market Revenue, By Therapy Type, 2025-2035

9.2.5. North America Market Revenue, By Stages, 2025-2035

9.2.6. North America Market Revenue, By End-user, 2025-2035

9.2.7. The U.S.

9.2.7.1. U.S. Market Revenue, By Service Type, 2025-2035

9.2.7.2. U.S. Market Revenue, By Application, 2025-2035

9.2.7.3. U.S. Market Revenue, By Therapy Type, 2025-2035

9.2.7.4. U.S. Market Revenue, By Stages, 2025-2035

9.2.7.5. U.S. Market Revenue, By End-user, 2025-2035

9.2.8. Canada

9.2.8.1. Canada Market Revenue, By Service Type, 2025-2035

9.2.8.2. Canada Market Revenue, By Application, 2025-2035

9.2.8.3. Canada Market Revenue, By Therapy Type, 2025-2035

9.2.8.4. Canada Market Revenue, By Stages, 2025-2035

9.2.8.5. Canada Market Revenue, By End-user, 2025-2035

9.3. Europe

9.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)

9.3.2. Europe Market Revenue, By Service Type, 2025-2035

9.3.3. Europe Market Revenue, By Application, 2025-2035

9.3.4. Europe Market Revenue, By Therapy Type, 2025-2035

9.3.5. Europe Market Revenue, By Stages, 2025-2035

9.3.6. Europe Market Revenue, By End-user, 2025-2035

9.3.7. Germany

9.3.7.1. Germany Market Revenue, By Service Type, 2025-2035

9.3.7.2. Germany Market Revenue, By Application, 2025-2035

9.3.7.3. Germany Market Revenue, By Therapy Type, 2025-2035

9.3.7.4. Germany Market Revenue, By Stages, 2025-2035

9.3.7.5. Germany Market Revenue, By End-user, 2025-2035

9.3.8. France

9.3.8.1. France Market Revenue, By Service Type, 2025-2035

9.3.8.2. France Market Revenue, By Application, 2025-2035

9.3.8.3. France Market Revenue, By Therapy Type, 2025-2035

9.3.8.4. France Market Revenue, By Stages, 2025-2035

9.3.8.5. France Market Revenue, By End-user, 2025-2035

9.3.9. U.K.

9.3.9.1. U.K. Market Revenue, By Service Type, 2025-2035

9.3.9.2. U.K. Market Revenue, By Application, 2025-2035

9.3.9.3. U.K. Market Revenue, By Therapy Type, 2025-2035

9.3.9.4. U.K. Market Revenue, By Stages, 2025-2035

9.3.9.5. U.K. Market Revenue, By End-user, 2025-2035

9.3.10. Italy

9.3.10.1. Italy Market Revenue, By Service Type, 2025-2035

9.3.10.2. Italy Market Revenue, By Application, 2025-2035

9.3.10.3. Italy Market Revenue, By Therapy Type, 2025-2035

9.3.10.4. Italy Market Revenue, By Stages, 2025-2035

9.3.10.5. Italy Market Revenue, By End-user, 2025-2035

9.3.11. Spain

9.3.11.1. Spain Market Revenue, By Service Type, 2025-2035

9.3.11.2. Spain Market Revenue, By Application, 2025-2035

9.3.11.3. Spain Market Revenue, By Therapy Type, 2025-2035

9.3.11.4. Spain Market Revenue, By Stages, 2025-2035

9.3.11.5. Spain Market Revenue, By End-user, 2025-2035

9.3.12. Rest of Europe

9.3.12.1. Rest of Europe Market Revenue, By Service Type, 2025-2035

9.3.12.2. Rest of Europe Market Revenue, By Application, 2025-2035

9.3.12.3. Rest of Europe Market Revenue, By Therapy Type, 2025-2035

9.3.12.4. Rest of Europe Market Revenue, By Stages, 2025-2035

9.3.12.5. Rest of Europe Market Revenue, By End-user, 2025-2035

9.4. Asia Pacific

9.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)

9.4.2. Asia Pacific Market Revenue, By Service Type, 2025-2035

9.4.3. Asia Pacific Market Revenue, By Application, 2025-2035

9.4.4. Asia Pacific Market Revenue, By Therapy Type, 2025-2035

9.4.5. Asia Pacific Market Revenue, By Stages, 2025-2035

9.4.6. Asia Pacific Market Revenue, By End-user, 2025-2035

9.4.7. China

9.4.7.1. China Market Revenue, By Service Type, 2025-2035

9.4.7.2. China Market Revenue, By Application, 2025-2035

9.4.7.3. China Market Revenue, By Therapy Type, 2025-2035

9.4.7.4. China Market Revenue, By Stages, 2025-2035

9.4.7.5. China Market Revenue, By End-user, 2025-2035

9.4.8. Japan

9.4.8.1. Japan Market Revenue, By Service Type, 2025-2035

9.4.8.2. Japan Market Revenue, By Application, 2025-2035

9.4.8.3. Japan Market Revenue, By Therapy Type, 2025-2035

9.4.8.4. Japan Market Revenue, By Stages, 2025-2035

9.4.8.5. Japan Market Revenue, By End-user, 2025-2035

9.4.9. India

9.4.9.1. India Market Revenue, By Service Type, 2025-2035

9.4.9.2. India Market Revenue, By Application, 2025-2035

9.4.9.3. India Market Revenue, By Therapy Type, 2025-2035

9.4.9.4. India Market Revenue, By Stages, 2025-2035

9.4.9.5. India Market Revenue, By End-user, 2025-2035

9.4.10. Australia

9.4.10.1. Australia Market Revenue, By Service Type, 2025-2035

9.4.10.2. Australia Market Revenue, By Application, 2025-2035

9.4.10.3. Australia Market Revenue, By Therapy Type, 2025-2035

9.4.10.4. Australia Market Revenue, By Stages, 2025-2035

9.4.10.5. Australia Market Revenue, By End-user, 2025-2035

9.4.11. South Korea

9.4.11.1. South Korea Market Revenue, By Service Type, 2025-2035

9.4.11.2. South Korea Market Revenue, By Application, 2025-2035

9.4.11.3. South Korea Market Revenue, By Therapy Type, 2025-2035

9.4.11.4. South Korea Market Revenue, By Stages, 2025-2035

9.4.11.5. South Korea Market Revenue, By End-user, 2025-2035

9.4.12. Singapore

9.4.12.1. Singapore Market Revenue, By Service Type, 2025-2035

9.4.12.2. Singapore Market Revenue, By Application, 2025-2035

9.4.12.3. Singapore Market Revenue, By Therapy Type, 2025-2035

9.4.12.4. Singapore Market Revenue, By Stages, 2025-2035

9.4.12.5. Singapore Market Revenue, By End-user, 2025-2035

9.4.13. Rest of Asia Pacific

9.4.13.1. Rest of Asia Pacific Market Revenue, By Service Type, 2025-2035

9.4.13.2. Rest of Asia Pacific Market Revenue, By Application, 2025-2035

9.4.13.3. Rest of Asia Pacific Market Revenue, By Therapy Type, 2025-2035

9.4.13.4. Rest of Asia Pacific Market Revenue, By Stages, 2025-2035

9.4.13.5. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

9.5. Latin America

9.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)

9.5.2. Latin America Market Revenue, By Service Type, 2025-2035

9.5.3. Latin America Market Revenue, By Application, 2025-2035

9.5.4. Latin America Market Revenue, By Therapy Type, 2025-2035

9.5.5. Latin America Market Revenue, By Stages, 2025-2035

9.5.6. Latin America Market Revenue, By End-user, 2025-2035

9.5.7. Brazil

9.5.7.1. Brazil Market Revenue, By Service Type, 2025-2035

9.5.7.2. Brazil Market Revenue, By Application, 2025-2035

9.5.7.3. Brazil Market Revenue, By Therapy Type, 2025-2035

9.5.7.4. Brazil Market Revenue, By Stages, 2025-2035

9.5.7.5. Brazil Market Revenue, By End-user, 2025-2035

9.5.8. Argentina

9.5.8.1. Argentina Market Revenue, By Service Type, 2025-2035

9.5.8.2. Argentina Market Revenue, By Application, 2025-2035

9.5.8.3. Argentina Market Revenue, By Therapy Type, 2025-2035

9.5.8.4. Argentina Market Revenue, By Stages, 2025-2035

9.5.8.5. Argentina Market Revenue, By End-user, 2025-2035

9.5.9. Mexico

9.5.9.1. Mexico Market Revenue, By Service Type, 2025-2035

9.5.9.2. Mexico Market Revenue, By Application, 2025-2035

9.5.9.3. Mexico Market Revenue, By Therapy Type, 2025-2035

9.5.9.4. Mexico Market Revenue, By Stages, 2025-2035

9.5.9.5. Mexico Market Revenue, By End-user, 2025-2035

9.5.10. Rest of Latin America

9.5.10.1. Rest of Latin America Market Revenue, By Service Type, 2025-2035

9.5.10.2. Rest of Latin America Revenue, By Application, 2025-2035

9.5.10.3. Rest of Latin America Market Revenue, By Therapy Type, 2025-2035

9.5.10.4. Rest of Latin America Market Revenue, By Stages, 2025-2035

9.5.10.5. Rest of Latin America Market Revenue, By End-user, 2025-2035

9.6. MEA

9.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)

9.6.2. MEA Market Revenue, By Service Type, 2025-2035

9.6.3. MEA Market Revenue, By Application, 2025-2035

9.6.4. MEA Market Revenue, By Therapy Type, 2025-2035

9.6.5. MEA Market Revenue, By Stages, 2025-2035

9.6.6. MEA Market Revenue, By End-user, 2025-2035

9.6.7. GCC Countries

9.6.7.1. GCC Countries Market Revenue, By Service Type, 2025-2035

9.6.7.2. GCC Countries Market Revenue, By Application, 2025-2035

9.6.7.3. GCC Countries Market Revenue, By Therapy Type, 2025-2035

9.6.7.4. GCC Countries Market Revenue, By Stages, 2025-2035

9.6.7.5. GCC Countries Market Revenue, By End-user, 2025-2035

9.6.8. South Africa

9.6.8.1. South Africa Market Revenue, By Service Type, 2025-2035

9.6.8.2. South Africa Market Revenue, By Application, 2025-2035

9.6.8.3. South Africa Market Revenue, By Therapy Type, 2025-2035

9.6.8.4. South Africa Market Revenue, By Stages, 2025-2035

9.6.8.5. South Africa Market Revenue, By End-user, 2025-2035

9.6.9. Rest of Middle-East & Africa

9.6.9.1. Rest of Middle-East & Africa Market Revenue, By Service Type, 2025-2035

9.6.9.2. Rest of Middle-East & Africa Market Revenue, By Application, 2025-2035

9.6.9.3. Rest of Middle-East & Africa Market Revenue, By Therapy Type, 2025-2035

9.6.9.4. Rest of Middle-East & Africa Market Revenue, By Stages, 2025-2035

9.6.9.5. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

10. Company Profile

10.1. Lonza

10.1.1. Business Overview

10.1.2. Financial Performance

10.1.3. Product/Service Offerings

10.1.4. Strategies & recent developments

10.1.5. SWOT Analysis

10.2. Catalent

10.2.1. Business Overview

10.2.2. Financial Performance

10.2.3. Product/Service Offerings

10.2.4. Strategies & recent developments

10.2.5. SWOT Analysis

10.3. Wuxi Advanced Therapies

10.3.1. Business Overview

10.3.2. Financial Performance

10.3.3. Product/Service Offerings

10.3.4. Strategies & recent developments

10.3.5. SWOT Analysis

10.4. Thermo Fisher Scientific

10.4.1. Business Overview

10.4.2. Financial Performance

10.4.3. Product/Service Offerings

10.4.4. Strategies & recent developments

10.4.5. SWOT Analysis

10.5. Charles River Laboratories

10.5.1. Business Overview

10.5.2. Financial Performance

10.5.3. Product/Service Offerings

10.5.4. Strategies & recent developments

10.5.5. SWOT Analysis

10.6. Novartis AG

10.6.1. Business Overview

10.6.2. Financial Performance

10.6.3. Product/Service Offerings

10.6.4. Strategies & recent developments

10.6.5. SWOT Analysis

10.7. AGC Biologics

10.7.1. Business Overview

10.7.2. Financial Performance

10.7.3. Product/Service Offerings

10.7.4. Strategies & recent developments

10.7.5. SWOT Analysis

10.8. OmniaBio

10.8.1. Business Overview

10.8.2. Financial Performance

10.8.3. Product/Service Offerings

10.8.4. Strategies & recent developments

10.8.5. SWOT Analysis

10.9. Rentschler Biopharma SE

10.9.1. Business Overview

10.9.2. Financial Performance

10.9.3. Product/Service Offerings

10.9.4. Strategies & recent developments

10.9.5. SWOT Analysis

10.10. Fujifilm Diosynth Biotechnologies

10.10.1. Business Overview

10.10.2. Financial Performance

10.10.3. Product/Service Offerings

10.10.4. Strategies & recent developments

10.10.5. SWOT Analysis

10.11. Cytiva

10.11.1. Business Overview

10.11.2. Financial Performance

10.11.3. Product/Service Offerings

10.11.4. Strategies & recent developments

10.11.5. SWOT Analysis

10.12. SK Pharmteco Inc.

10.12.1. Business Overview

10.12.2. Financial Performance

10.12.3. Product/Service Offerings

10.12.4. Strategies & recent developments

10.12.5. SWOT Analysis

10.13. Evotec

10.13.1. Business Overview

10.13.2. Financial Performance

10.13.3. Product/Service Offerings

10.13.4. Strategies & recent developments

10.13.5. SWOT Analysis

10.14. Merck KGaA

10.14.1. Business Overview

10.14.2. Financial Performance

10.14.3. Product/Service Offerings

10.14.4. Strategies & recent developments

10.14.5. SWOT Analysis

10.15. BioNTech SE

10.15.1. Business Overview

10.15.2. Financial Performance

10.15.3. Product/Service Offerings

10.15.4. Strategies & recent developments

10.15.5. SWOT Analysis